Pinealon (Glu-Asp-Arg) is a synthetic tripeptide developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It is part of the broader Khavinson 'short peptide' bioregulator program, which has…